Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty | Zendy

Mustafa Yurtdaş | Zendy; Yalın Tolga Yaylalı | Zendy; Nesim Aladağ | Zendy; Mahmut Özdemir | Zendy; Memiş Hilmi Atay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acute Serious Thrombocytopenia Associated with Intracoronary Tirofiban Use for Primary Angioplasty

Author(s) -

Mustafa Yurtdaş,

Yalın Tolga Yaylalı,

Nesim Aladağ,

Mahmut Özdemir,

Memiş Hilmi Atay

Publication year - 2014

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2014/190149

Subject(s) - tirofiban , medicine , cardiology , percutaneous coronary intervention , myocardial infarction , complication , incidence (geometry) , angioplasty , acute coronary syndrome , primary angioplasty , physics , optics

Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-old man who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research